Showing results (41-50 of 231) with videos related to
Sort By:
Pageof 24
Aging & Mental Health|August 30, 2006
Impact of diagnostic disclosure in dementia on patients and carers: qualitative case series analysisE Derksen, M Vernooij-Dassen, F Gillissen, et al.Nederlands Tijdschrift Voor Geneeskunde|February 2, 2017
[Amyloid PET imaging in patients with Alzheimer's disease]P Scheltens, M Zwan, R Ossenkoppele, et al.Human Brain Mapping|March 30, 2000
FMRI of visual encoding: reproducibility of activationW C Machielsen, S A Rombouts, F Barkhof, et al.Acta Neurologica Scandinavica|June 1, 1993
Autosomal recessive paraparesis with amyotrophy of the hands and feetR P Bruyn, P Scheltens, J Lycklama à Nijeholt, et al.Developmental Medicine and Child Neurology|August 1, 1993
A case of macrocephaly, hydrocephalus, megacerebellum, white matter abnormalities and Rosenthal fibresM Torreman, L M Smit, P van der Valk, et al.Archives of Neurology|December 1, 1992
Frontal lobe dysfunction in unilateral lenticulostriate infarcts. Prominent role of cortical lesionsO Godefroy, M Rousseaux, D Leys, et al.Neurology|May 1, 1995
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal agingP Scheltens, F Barkhof, D Leys, et al.Alzheimer'S Research & Therapy|May 19, 2021
A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation studyE A J Willemse, P Scheltens, C E Teunissen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2006
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitusG J Biessels, F-E De Leeuw, J Lindeboom, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's diseaseS A R B Rombouts, F Barkhof, C S Van Meel, et al.Pageof 24